ASX stock of the day: This ASX healthcare share jumped 13% today as it commenced trials of its COVID-19 treatment | ||
Wednesday, 6 May 2020 ()
Shares in Mesoblast Limited (ASX: MSB) are up more than 13% today after the healthcare company announced the first patients had been dosed in a trial of its COVID-19 treatment. The post ASX stock of the day: This ASX healthcare share jumped 13% today as it commenced trials of its COVID-19 treatment appeared first on Motley... |